A Phase III Study of Fruquintinib in Combination With Paclitaxel in Second Line Gastric Cancer(FRUTIGA)

Condition:   Advanced Gastric Cancer Interventions:   Combination Product: fruquintinib +paclitaxel;   Combination Product: fruquintinib placebo + paclitaxel Sponsors:   Hutchison Medipharma Limited;   Sun Yat-sen University Not yet recruiting - verified July 2017 (Source: ClinicalTrials.gov)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2tyExWB
via IFTTT